home / stock / ntra / ntra news


NTRA News and Press, Natera Inc. From 01/09/21

Stock Information

Company Name: Natera Inc.
Stock Symbol: NTRA
Market: NASDAQ
Website: natera.com

Menu

NTRA NTRA Quote NTRA Short NTRA News NTRA Articles NTRA Message Board
Get NTRA Alerts

News, Short Squeeze, Breakout and More Instantly...

NTRA - These Were the 5 Best Diagnostics Stocks of 2020

It's hard to think of an industry that was more impacted by the 2020 COVID pandemic than diagnostics. The often-overlooked part of the healthcare system sprang into action, testing more than 250 million people last year in the U.S. alone. And interestingly, some testing companies performed ...

NTRA - Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference

Natera to Webcast Live Presentation at the 39th Annual J.P. Morgan Healthcare Conference PR Newswire SAN CARLOS, Calif. , Jan. 5, 2021 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced t...

NTRA - U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent

U.S. Patent Office Upholds Validity of Natera's Early Priority Date '592 cfDNA Patent SAN CARLOS, Calif. , Dec. 18, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA (cfDNA) testing, is pleased that the United States Paten...

NTRA - Natera: Conceive, Deliver, Thrive

Increased adoption and expansion of products resulting in significant rises in volume. Producing meaningful improvements in revenues and costs per unit. Confidently raising 2020 guidance. For further details see: Natera: Conceive, Deliver, Thrive

NTRA - New Signatera(TM) Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial

New Signatera™ Data to be Presented at the 2020 ESMO IO Congress from the Phase III IMvigor010 Trial SAN CARLOS, Calif. , Dec. 9, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that n...

NTRA - Natera to Present New Immunotherapy Monitoring Data at SABCS 2020

Natera to Present New Immunotherapy Monitoring Data at SABCS 2020 SAN CARLOS, Calif. , Dec. 8, 2020 /PRNewswire/ -- Natera,Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced it will present new data on its personalized and ...

NTRA - Another large U.S. commercial insurer expands coverage of non-invasive prenatal tests to all singleton pregnancies

Natera (NTRA) announces that the second-largest U.S. commercial insurer has extended coverage of non-invasive prenatal tests ((NIPT)) to all singleton pregnancies. The largest player announced the same several days ago.The expanded coverage bodes well for the company's Panorama molecular test...

NTRA - Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies

Second Largest Commercial Insurer Covers Non-Invasive Prenatal Testing for All Pregnancies SAN CARLOS, Calif. , Dec. 3, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in cell-free DNA testing, today announced that the second largest...

NTRA - Natera gains 4% on expanded medical policy coverage for all pregnancies

Natera (NTRA) says that the largest health plan in the United States has extended coverage of Non-Invasive Prenatal Testing ((NIPT)) to all pregnancies.The expanded coverage comes only a few months after the publication of recent studies has shown support for offering aneuploidy scr...

NTRA - Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies

Largest U.S. Health Plan Now Covers Non-Invasive Prenatal Testing (NIPT) for all Pregnancies PR Newswire SAN CARLOS, Calif., Dec. 1, 2020 SAN CARLOS, Calif. , Dec. 1, 2020 /PRNewswire/ -- Natera, Inc. (NASDAQ: NTRA), a pioneer and global leader in...

Previous 10 Next 10